[O1] Oral Presentations 1 | Symposium of AMED SCARDA Japan Initiative for World-leading Vaccine Research and Development Centers

Advanced Search

Session Details

Oral Presentations

[O1]Oral Presentations 1

Mon. Mar 2, 2026 1:50 PM - 3:20 PM JST
Mon. Mar 2, 2026 4:50 AM - 6:20 AM UTC

Kobe Portopia Hotel(South Wing 1F Ohwada)

【R&D I, III】【Joint Research between Support Institutions and R＆D centers】

1:50 PM - 2:00 PM JST(4:50 AM - 5:00 AM UTC)R&D IVaccine Science

[O1-01]Vaccine's off-target effects and the role of adjuvant

*Ken J ISHII^1,2,3 (1. Div. Vaccine Science, The Institute of Medical Science, The University of Tokyo (Japan), 2. International Vaccine Design Center (VDesC), The Institute of Medical Science, The University of Tokyo (Japan), 3. UTOPIA, The University of Tokyo (Japan))

Comment()

2:00 PM - 2:10 PM JST(5:00 AM - 5:10 AM UTC)R&D IImmunology

[O1-02]Development of universal off-the-shelf T cell medicine produced from pluripotent stem cells for the treatment of COVID-19

*Hiroshi Kawamoto¹ (1. Institute for Life and Medical Sciences, Kyoto University (Japan))

Comment()

2:10 PM - 2:20 PM JST(5:10 AM - 5:20 AM UTC)R&D IIIClinical Research

[O1-03]Clinical Trials at UTOPIA

*Michiko Koga^1,2, Hiroshi Yotsuyanagi^2,3 (1. The UTOPIA Center, The University of Tokyo (Japan), 2. IMSUT Hospital, the Institute of Medical Science, the University of Tokyo (Japan), 3. Japan Institute for Health Security (Japan))

Comment()

2:20 PM - 2:30 PM JST(5:20 AM - 5:30 AM UTC)R&D IIIChemistryCandidate for the Oral Presentation Award for Early-career Researchers

[O1-04E]mRNA delivery utilizing light

*Takahiro Nomoto¹ (1. Graduate School of Arts and Sciences, The University of Tokyo (Japan))

Comment()

2:30 PM - 2:40 PM JST(5:30 AM - 5:40 AM UTC)R&D IIIGenetics/Genome ScienceCandidate for the Oral Presentation Award for Early-career Researchers

[O1-05E]Current Status and Support Services for Advanced Genomic and Omics Analysis Technologies

*Akinori Kanai¹, Yutaka Suzuki¹ (1. Graduate School of Frontier Sciences, The University of Tokyo (Japan))

Comment()

2:40 PM - 2:50 PM JST(5:40 AM - 5:50 AM UTC)R&D IIIVirology

[O1-06]Efficacy of baloxavir marboxil and oseltamivir phosphate against H5N1 highly pathogenic avian influenza virus in young and old cynomolgus macaques

*Yasushi Itoh¹, Maki Kiso², Hirohito Ishigaki¹, Kiyoko Iwatsuki-Horimoto², Kenichi Otaki¹, Mutsumi Ito², Masaki Imai², Yukihiro Matsukawa¹, Ryuta Uraki², Seiya Yamayoshi², Yoshihiro Kawaoka² (1. Department of Pathology, Shiga University of Medical Science (Japan), 2. The UTOPIA Center, The University of Tokyo (Japan))

Comment()

2:50 PM - 3:00 PM JST(5:50 AM - 6:00 AM UTC)R&D IIIVirology

[O1-07]Establishment of a novel non-human primate model of infectious disease: Toward accelerating vaccine development

*Emiko Urano¹, Yasuhiro Yasutomi¹ (1. Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition (Japan))

Comment()

3:00 PM - 3:10 PM JST(6:00 AM - 6:10 AM UTC)R&D IIIImmunology

[O1-08]Establishment of a Single-Cell Analysis Platform Using Nasopharyngeal Swab Samples

*Akari Suzuki¹, Junna Kawasaki^2,3, Sho Miyamoto^2,3, Tadaki Suzuki^2,3, Syuji Yonekura⁴, Kohtaro Fujihashi⁵, Kazuhiko Yamamoto¹ (1. Center for integrative medical science, RIKEN (Japan), 2. Department of Infectious Disease Pathobiology, Graduate School of Medicine, Chiba University (Japan), 3. Department of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security (Japan), 4. Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University (Japan), 5. Department of Human Mucosal Vaccinology, Chiba University Hospital (Japan))

Comment()

3:10 PM - 3:20 PM JST(6:10 AM - 6:20 AM UTC)R&D IIIImmunology

[O1-09]Understanding the Persistence of Vaccine-Induced Immunity Through Multi-Omics Profiling

*Masato Kubo¹ (1. Kyoto university (Japan))

Comment()

Back to Category List